VIRX — Viracta Therapeutics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMicro CapSucker Stock

Annual balance sheet for Viracta Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	29.1	20.4	104	91	53.7
Net Total Receivables	—	—	—	—	0.281
Prepaid Expenses
Total Other Current Assets
Total Current Assets	36.3	22.1	105	93.7	55
Net Property, Plant And Equipment	0.82	0.273	0.882	0.414	0.464
Other Long Term Assets
Total Assets	37.2	23.2	109	96	56.7
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Current Liabilities	9.42	3.31	9.08	10	38.4
Long Term Debt
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	9.7	3.31	14.2	34.9	38.4
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	27.5	19.9	94.4	61.1	18.3
Total Liabilities & Shareholders' Equity	37.2	23.2	109	96	56.7
Total Common Shares Outstanding
Total Preferred Shares Outstanding